Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -70.27% | -50.66% | 0.97% | -18.55% | -44.59% |
| Total Depreciation and Amortization | 29.00% | 30.66% | 22.80% | 23.77% | 16.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,806.48% | 124.88% | -3.61% | -3,146.85% | -105.83% |
| Change in Net Operating Assets | 574.11% | 267.87% | -73.79% | 28.26% | 49.05% |
| Cash from Operations | 0.85% | -16.55% | -35.32% | -28.07% | -28.80% |
| Capital Expenditure | 53.35% | 70.08% | -308.05% | -710.12% | 87.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -180.55% | -101.04% | 101.10% | -- |
| Cash from Investing | -5,232.54% | -193.19% | -113.84% | 88.49% | 87.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 366.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -237.01% | -99.94% | -28.16% | -303.56% | -203.83% |
| Cash from Financing | -309.67% | -99.99% | -40.78% | 356.35% | -186.63% |
| Foreign Exchange rate Adjustments | -301.73% | 94.97% | -437.68% | 289.92% | 178.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.30% | -277.53% | -349.69% | 1,752.85% | -17.03% |